Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2001; 38:1485-1490
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsutamoto, T.
Right arrow Articles by Kinoshita, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsutamoto, T.
Right arrow Articles by Kinoshita, M.

Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy

Takayoshi Tsutamoto, MD*,*, Atsuyuki Wada, MD*, Keiko Maeda, MD*, Naoko Mabuchi, MD*, Masaru Hayashi, MD*, Takashi Tsutsui, MD*, Masato Ohnishi, MD*, Masanori Fujii, MD*, Takehiro Matsumoto, MD*, Takashi Yamamoto, MD*, Xinwen Wang, MD*, Shigeru Asai, PhD{dagger}, Tetsuo Tsuji, PhD{dagger}, Hitoshi Tanaka, PhD{dagger}, Yoshihiko Saito, MD{ddagger}, Koichiro Kuwahara, MD{ddagger}, Kazuwa Nakao, MD{ddagger} and Masahiko Kinoshita, MD*

* First Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan
{dagger} Diagnostic Department, Shionogi & Co., Osaka, Japan
{ddagger} Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan



View larger version (19K):

[in a new window]
 
Figure 1 Plasma cardiotrophin-1 (CT-1) concentrations in control subjects and in congestive heart failure (CHF) patients with dilated cardiomyopathy. Mild CHF = New York Heart Association (NYHA) functional class II; severe CHF = NYHA functional class III–IV. *p < 0.05 versus the value of control subjects; #p < 0.05 versus the value of the mild CHF.

 


View larger version (16K):

[in a new window]
 
Figure 2 Plasma cardiotrophin-1 (CT-1) concentrations in patients with dilated cardiomyopathy. Patients were classified into two groups: small left ventricular mass index (LVMI) group and large LVMI, based on the median value of LV mass index. *p < 0.01 versus the value in the small LVMI group.

 


View larger version (21K):

[in a new window]
 
Figure 3 Correlation between the plasma cardiotrophin-1 (CT-1) concentrations and the left ventricular (LV) mass index in patients with dilated cardiomyopathy.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement